Design of β-hairpin peptides for modulation of cell adhesion by β-turn constraint

Journal of Medicinal Chemistry

Volumn 52, Issue 3, 2009, Pages 726-736

  Giddu, Sumana ^a   Subramanian, Vivekanandan ^b,c   Yoon, Ho Sup ^b   Satyanarayanajois, Seetharama D ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; GLYCINE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; PEPTIDE DERIVATIVE; PROLINE; PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BETA SHEET; BETA TURN; CELL ADHESION; CELL VIABILITY; CIRCULAR DICHROISM; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOREGULATION; INHIBITION KINETICS; MOLECULAR DYNAMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; SIMULATION; ANIMAL; CELL STRAIN CACO 2; CELL SURVIVAL; CHEMISTRY; DRUG DESIGN; DRUG EFFECT; ERYTHROCYTE; IMMUNOLOGY; LEUKEMIA CELL LINE; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE; ROSETTE FORMATION; SHEEP; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD2; ANTIGENS, CD58; CACO-2 CELLS; CELL ADHESION; CELL SURVIVAL; DRUG DESIGN; ERYTHROCYTES; HUMANS; JURKAT CELLS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDES; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; ROSETTE FORMATION; SHEEP; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 61449206310     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm8008212     Document Type: Article

References (64)

1. Van der Merwe, P. A.; Davis, S. J. Molecular interactions mediating T cell antigen recognition. Annu. Rev. Immunol. 2003, 21, 659-684.
2. Grakoui, A.; Bromley, S. K.; Sumen, C.; Davis, M. M.; Shaw, A. S.; Allen, P. M.; Dustin, M. L. The immunological synapse: a molecular machine controlling T cell activation. Science 1999, 285, 221-227.
3. Bromley, S. K.; Burack, W. R.; Johnson, K. G.; Somersalo, K.; Sims, T. N.; Sumen, C.; Davis, M. M.; Shaw, A. S.; Allen, P. M.; Dustin, M. L. The immunological synapse. Annu. Rev. Immunol. 2001, 19, 375-396.
4. Bierer, B. E.; Burakoff, S. J. T cell adhesion molecules. FASEB J. 1998, 2, 2584-2590.
5. Davis, S. J.; van der Merwe, P. A. The structure and ligand interactions of CD2: implications for T cell function. Immunol. Today 1996, 17, 177-187.
6. Davis, S. J.; Ikemizu, S.; Evans, E. J.; Fugger, L.; Bakker, T. L.; van der Merwe, P. A. The nature of molecular recognition by T-cells. Nat. Immunol. 2003, 4, 217-224.
7. Zaru, R.; Cameron, T. O.; Stern, L. J.; Muller, S.; Valitutti, S. Cutting edge: TCR engagement and triggering in the absence of large-scale molecular segregation at the T cell-APC contact site. J. Immunol. 2002, 168, 4287-4291.
8. Wang, J.; Smolyar, A.; Tan, K.; Liu, J.; Kim, M.; Sun, Z. J.; Wagner, G.; Reinherz, E. L. Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors. Cell 1999, 97, 791-803.
9. Bachmann, M. F.; Barner, M.; Kopf, M. CD2 sets quantitative thresholds in T cell activation. J. Exp. Med. 1999, 190, 1383-1391.
10. Aruffo, A.; Hollenbaugh, D. Therapeutic intervention with inhibitors of co-stimulatory pathways in autoimmune disease. Curr. Opin. Immunol. 2001, 13, 683-686.
11. da Silva, A. J.; Brickelmaier, M.; Majeau, G. R.; Li, Z.; Su, L.; Hsu, Y. M.; Hochman, P. S. Alefacept, an immunomodulatory recombinant LFA-3/IgG1 fusion protein, induces CD16 signaling and CD2/CD16- dependent apoptosis of CD2+ cells. J. Immunol. 2002, 168, 4462-4471.
12. Hoffmann, J. C.; Herklotz, C.; Zeidler, H.; Bayer, B.; Rosenthal, H.; Westermann, J. Initiation and perpetuation of rat adjuvant arthritis is inhibited by the anti-CD2 monoclonal antibody (mAb) OX34. Ann. Rheum. Dis. 1997, 56, 716-722.
13. Sido, B.; Dengler, T. J.; Otto, G. Differential immunosuppressive activity of monoclonal CD2 antibodies on allograft rejection versus specific antibody production. Eur. J. Immunol. 1998, 28, 1347-1357.
14. Mrowietz, U. Treatment targeted to cell surface epitopes. Clin Exp). Dermatol. 2002, 27, 591-596.
15. Braun, J.; Sieper, J. Role of novel biological therapies in psoriatic arthritis: effects on joints and skin. BioDrugs 2003, 17, 187-199.
16. Przepiorka, D.; Phillips, G. L.; Ratanatharathorn, V.; Cottler-Fox, M.; Sehn, L. H.; Antin, J. H.; LeBherz, D.; Awwad, M.; Hope, J.; McClain, J. B. A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease. Blood 1998, 92, 4066-4071.
17. Squifflet, J. P.; Besse, T.; Malaise, J.; Mourad, M.; Delcorde, C.; Hope, J. A.; Pirson, Y. BTI-322 for induction therapy after renal transplantation: a randomized study. Transplant. Proc. 1997, 29, 317-319.
18. Besse, T.; Malaise, J.; Mourad, M.; Pirson, Y.; Hope, J.; Awwad, M.; White-Scharf, M.; Squifflet, J. P. Prevention of rejection with BTI- 322 after renal transplantation (results at 9 months). Transplant.Proc. 1997, 29, 2425-2426.
19. Spitzer, T. R.; McAfee, S. L.; Dey, B. R.; Colby, C.; Hope, J.; Grossberg, H. T. R.; Preffer, F.; Shaffer, J.; Alexander, S. I.; Sachs, D. H.; Sykes, M. Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies. Transplantation 2003, 75, 1748-1751.
20. Ulbrich, H.; Eriksson, E. E.; Lindbom, L. Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends Pharmacol. Sci. 2003, 24, 640-647.
21. Anderson, M. E.; Siahaan, T. J. Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors. Peptides 2003, 24, 487-501.
22. Jois, S. D.; Jining, L.; Nagarajarao, L. M. Targeting T-cell adhesion molecules for drug-design. Curr. Pharm. Des. 2006, 12, 2797-2812.
23. Jining, L.; Makagiansar, I.; Yusuf-Makagiansar, H.; Chow, V. T.; Siahaan, T. J.; Jois, S. D. Design, structure and biological activity of beta-turn peptides of CD2 protein for inhibition of T-cell adhesion. Eur. J. Biochem. 2004, 271, 2873-2886.
24. Liu, J.; Ying, J.; Chow, V. T.; Hruby, V. J.; Satyanarayanajois, S. D. Structure-activity studies of peptides from the "hot spot" region of human CD2 protein: development of peptides for immunomodulation. J. Med. Chem. 2005, 48, 6236-6249.
25. Liu, J.; Li, C.; Ke, S.; Satyanarayanajois, S. D. Structure-based rational design of beta-hairpin peptides from discontinuous epitopes of cluster of differentiation 2 (CD2) protein to modulate cell adhesion interaction. J. Med. Chem. 2007, 50, 4038-4047.
26. Li, C.; Satyanarayanajois, S. D. Structure-function studies of peptides for cell adhesion inhibition: identification of key residues by alanine mutation and peptide-truncation approach. Peptides 2007, 28, 1498-1508.
27. Blanco, F. J.; Jimenez, M. A.; Herranz, J.; Rico, M.; Santoro, J.; Nieto, J. L. NMR evidence of a short linear peptide that folds into a β-turn in aqueous solution. J. Am. Chem. Soc. 1993, 115, 5887-5888.
28. Hutchinson, E. G.; Thronton, J. A revised set of potentials for β-turn formation in proteins. Protein Sci. 1994, 3, 2207-2216.
29. Fesinmeyer, R. M.; Hudson, F. M.; Olsen, K. A.; White, G. W.; Euser, A.; Andersen, N. H. Chemical shifts provide fold populations and register of beta hairpins and beta sheets. J. Biomol. NMR. 2005, 33, 213-231.
30. Liu, J.; Chow, V. T.; Jois, S. D. A novel, rapid and sensitive heterotypic cell adhesion assay for CD2-CD58 interaction, and its application for testing inhibitory peptides. J. Immunol. Methods 2004, 291, 39-49.
31. Albert-Wolf, M.; Meuer, S. C.; Wallich, R. Dual function of recombinant human CD58: inhibition of T-cell adhesion and activation via the CD2 pathway. Int. Immunol. 1991, 3, 1335-1347.
32. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 5, 55-63.
33. Perczel, A.; Fasman, G. D. Analysis of the circular dichroism spectrum of proteins using the convex constraint algorithm: a practical guide. Anal. Biochem. 1992, 203, 83-93.
34. Perczel, A.; Fasman, G. D. Quantitative analysis of cyclic β-turn models. Protein Sci. 1992, 1, 378-395.
35. Mahalakshmi, R.; Ragothama, S.; Balaram, P. NMR analysis of aromatic interactions in designed peptide β-hairpins. J. Am. Chem. Soc. 2006, 128, 1125-1138.
36. Dyer, R. B.; Maness, S. J.; Franzen, S.; Fesinmeyer, R. M.; Olsen, K. A.; Andersen, N. H. Hairpin folding dynamics: the cold-denatured state is predisposed for rapid refolding. Biochemistry 2005, 44, 10406-10415.
37. Bax, A.; Davis, D. G. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 1985, 65, 355-360.
38. Bax, A.; Davis, D. G. Practical aspects of two-dimensional transverse NOE spectroscopy. J. Magn. Reson. 1985, 63, 207-213.
39. Francart, C.; Wieruszeski, J. M.; Tartar, A.; Lippens, G. Structural and dynamic characterization of Pro cis/trans isomerization in a small cyclic peptide. J. Am. Chem. Soc. 1996, 118, 7019-7027.
40. 1H NMR parameters of common amino acid residues measured in aqueous solution of linear tetrapeptide H-Gly-Gly-X-Ala-OH. Biopolymers 1979, 18, 285-297.
41. Wishart, D. S.; Sykes, B. D.; Richards, F. M. The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry. 1992, 31, 1647-1651.
42. Wuthrich, K. NMR of Proteins and Nucleic Acids; John Wiley & Sons: New York, 1986.
43. Andersen, N. H.; Neidigh, J. W.; Harris, S. M.; Lee, G. M.; Liu, Z.; Tong, H. Extracting information from the temperature gradients of polypeptide NH chemical shifts. 1. The importance of conformational averaging. J. Am. Chem. Soc. 1997, 119, 8547-8561.
44. Rose, G. D.; Gierasch, L. M.; Smith, J. A. Turns in peptides and proteins. Adv. Protein Chem. 1985, 37, 1-109.
45. Constantine, K. L.; Mueller, L.; Andersen, N. H.; Tong, H.; Wandler, C. F.; Friedrichs, M. S.; Bruccoleri, R. E. Structural and dynamics properties of a βhairpin-forming linear peptide. 1. Modeling using ensemble averaged constraints. J. Am. Chem. Soc. 1995, 117, 10841-10854.
46. Anderson, N. H.; Olsen, K. A.; Fesinmeyer, M.; Tan, X.; Hudson, M. F.; Eidenschink, L. A.; Farazi, S. R. Minimization and optimization of designed β-hairpin folds. J. Am. Chem. Soc. 2006, 128, 6101-6110.
47. Kim, M.; Sun, Z. Y.; Byron, O.; Campbell, G.; Wagner, G.; Wang, J.; Reinherz, E. L. Molecular dissection of the CD2-C58 counter- receptor interface identifies CD2 Tyr86 and CD58 Lys34 residues as the functional "hot spot". J. Mol. Biol. 2001, 312, 711-720.
48. Gunasekaran, K.; Gomathi, L.; Ramakrishnan, C.; Chandrasekhar, J.; Balaram, P. Conformational interconversions in peptide β-turns: analysis of turns in proteins and computational estimates of barriers. J. Mol. Biol. 1998, 284, 1505-1516.
49. Rietman, B. H.; Folkers, P. J. M.; Folmer, R. H. A.; Tesser, G. I.; Hilbers, C. W. The solution structure of the synthetic circular peptide CGVSRQGKPYC. NMR studies of the folding of a synthetic model for the DNA-binding loop of the ssDNA-binding protein encoded by gene V of phage M13. Eur. J. Biochem. 1996, 238, 706-713.
50. εR1 a-chain mimics: a β-hairpin peptide and its retroenantiomer. J. Am. Chem. Soc. 1997, 119, 5321-5328.
51. de Alba, E.; Rico, M.; Jimenez, M. A. The turn sequence directs beta-strand alignment in designed beta-hairpins. Protein Sci. 1999, 8, 2234-2244.
52. Hruby, V. J. Designing peptide receptor agonists and antagonists. Nat. Rev. Drug Discovery 2002, 1, 847-858.
53. Santiveri, C. M.; Leon, E.; Rico, M.; Jimenez, M. A. Context-dependence of the contribution of disulfide bonds to beta-hairpin stability. Chemistry 2008, 14, 488-499.
54. Schumann, C.; Seyfarth, L.; Greiner, G.; Paegelow, I.; Reissmann, S. Synthesis and biological activity of new side chain and backbone cyclic bradykinin analogues. J. Pept. Res. 2003, 60, 128-140.
55. Handbook of Combinatorial and Solid Phase Organic Chemistry: A Guide to Principles, Products and Protocols; Advanced Chemtech: Louisville, KY, 1998; pp 329-372.
56. Lloyd-Williams, P.; Albericio, F.; Giralt, E. Chemical Approaches to the Synthesis of Peptides and Proteins; CRC: Boca Raton, FL, 1997; pp 19-82.
57. Gines, S.; Marino, M.; Mallol, J.; Canela, E. I.; Morimoto, C.; Callebaut, C.; Hovanessian, A.; Casado, V.; Lluis, C.; Franco, R. Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction. Biochem. J. 2002, 361, 203-209.
58. InsightII; Accelrys, Inc.: San Diego, CA. Insightll is a commercial, licensed molecular modeling software obtained from Accelrys, Inc. http://www.accelrys.com/products/insight/.
59. Sutcliffe, M. J. Structure Determination from NMR Data II. Computational Approaches. In NMR of Macromolecules: A Practical Approach; Roberts, G. C. K., Ed.; Oxford University Press: New York, 1993; pp 359-390.
60. Davis, I. W.; Leaver-Fay, A.; Chen, V. B.; Block, J. N.; Kapral, G. J.; Wang, X.; Murray, L. W., 3rd.; Snoeyink, J.; Richardson, J. S.; Richardson, D. C. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 2007, 35, W375-W383.
61. Koradi, R.; Billeter, M.; Wüthrich, K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graphics 1996, 14, 51-55.
62. Srinivasan, N.; Sowdhamini, R.; Ramakrishnan, C.; Balaram, P. Conformations of disulfide bridges in proteins. Int. J. Pept. Protein Res. 1990, 36, 147-155.
63. 1H NMR spectra of protein via double quantum filtering. Biochem. Biophys. Res. Commun. 1983, 117, 479-485.
64. Goddard, T. D.; Kneller, D. G. SPARKY3; University of California: San Francisco, CA; http://www.cgl.ucsf.edu/home/sparky/.